What this means
This is a study plan to test whether IV infusions of donor umbilical cord stem cells are safe for frailty. It is still recruiting, and no results have been posted yet.
Plain-English summary written by an AI model from the registry listing.
- Status
- Recruiting
- Who can join
- See eligibility
- Where
- 2 sites, including Florida
The science
- Registered title
- Safety of Cultured Allogeneic Adult Umbilical Cord or Placental Derived Mesenchymal Stem Cell Intravenous Infusion for Aging Frailty
- Trial ID
- NCT05018767 ↗
- Phase
- PHASE 1
- Study type
- interventional
- Conditions
- Frailty
- What is tested
- cultured allogeneic adult umbilical cord or placental derived mesenchymal stem cells
- Sponsor
- The Foundation for Orthopaedics and Regenerative Medicine
- Ages
- No minimum to no maximum
- Dates
- First posted Aug 24, 2021 · updated Oct 20, 2026
Registry summary
This trial will study the safety and efficacy of intravenous infusion of cultured allogeneic adult umbilical cord or placental derived mesenchymal stem cells for the treatment of Aging Frailty
Sites (2)
- Prodromos Stem Cell Institute, Naples, Florida, United States
- Prodromos Stem Cell Institute, Athens, Greece